172 related articles for article (PubMed ID: 37535448)
1. Occupational interstitial lung diseases.
Spagnolo P; Ryerson CJ; Guler S; Feary J; Churg A; Fontenot AP; Piciucchi S; Udwadia Z; Corte TJ; Wuyts WA; Johannson KA; Cottin V
J Intern Med; 2023 Dec; 294(6):798-815. PubMed ID: 37535448
[TBL] [Abstract][Full Text] [Related]
2. Occupational Contributions to Interstitial Lung Disease.
Reynolds C; Feary J; Cullinan P
Clin Chest Med; 2020 Dec; 41(4):697-707. PubMed ID: 33153688
[TBL] [Abstract][Full Text] [Related]
3. Interstitial Lung Diseases in Developing Countries.
Rivera-Ortega P; Molina-Molina M
Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741505
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
[TBL] [Abstract][Full Text] [Related]
5. Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.
Copeland CR; Collins BF; Salisbury ML
Chest; 2021 Jul; 160(1):219-230. PubMed ID: 33609518
[TBL] [Abstract][Full Text] [Related]
6. Dust-induced interstitial lung disease in the tropics.
Jindal SK; Aggarwal AN; Gupta D
Curr Opin Pulm Med; 2001 Sep; 7(5):272-7. PubMed ID: 11584175
[TBL] [Abstract][Full Text] [Related]
7. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
8. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
[TBL] [Abstract][Full Text] [Related]
9. Occupational interstitial lung disease.
Glazer CS; Newman LS
Clin Chest Med; 2004 Sep; 25(3):467-78, vi. PubMed ID: 15331187
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
Frank AL; Kreuter M; Schwarzkopf L
Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
[TBL] [Abstract][Full Text] [Related]
11. Scoping review of exposure questionnaires and surveys in interstitial lung disease.
Barnes H; Elmrayed S; Barber CM; Feary J; Lee CT; Gandhi S; Peters CE; Salisbury ML; Johannson KA
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754906
[TBL] [Abstract][Full Text] [Related]
12. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
13. Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.
Dhooria S; Sehgal IS; Agarwal R; Muthu V; Prasad KT; Kathirvel S; Garg M; Bal A; Aggarwal AN; Behera D
PLoS One; 2022; 17(7):e0271665. PubMed ID: 35862355
[TBL] [Abstract][Full Text] [Related]
14. [Update in interstitial lung disease 2023].
Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):44-49. PubMed ID: 38062694
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011.
Strâmbu I; Belaconi I; Stoicescu I; Ioniţă D; Cojocaru F; Niţă C; Dospinoiu D; Bumbăcea R
Pneumologia; 2013; 62(4):206-11. PubMed ID: 24734353
[TBL] [Abstract][Full Text] [Related]
16. [Interstitial lung diseases : Classification, differential diagnosis and treatment approaches in a heterogeneous group of chronic lung disorders].
Lederer C; Buschulte K; Hellmich B; Heußel CP; Kriegsmann M; Polke M; Kreuter M
Inn Med (Heidelb); 2023 Mar; 64(3):247-259. PubMed ID: 36786822
[TBL] [Abstract][Full Text] [Related]
17. Current perspective of progressive-fibrosing interstitial lung disease.
Kishaba T
Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
[TBL] [Abstract][Full Text] [Related]
18. Advances with pharmacotherapy for the treatment of interstitial lung disease.
Comes A; Sgalla G; Perrotta A; Richeldi L
Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
[TBL] [Abstract][Full Text] [Related]
19. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
[TBL] [Abstract][Full Text] [Related]
20. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
